drugset / Trial / NCT02123628

Antibiotic Treatment Duration for Non-Surgically-Treated Diabetic Foot Osteomyelitis

NCT02123628

Phase 4 Completed 40 enrolled Tourcoing Hospital
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of the study is to compare the efficacy and tolerance of 6- versus 12-week antibiotic therapy in patients with diabetic foot osteomyelitis treated medically.

Timeline

Start
2007-06
Primary completion
2010-06
Completion
2012-09

Drugs

EvaluationDrugModalityDoseRoute
Comparator Cefepime Small molecule 2 g Intravenous
Comparator Cefotaxime Small molecule 100 mg/kg Intravenous
Comparator Ceftriaxone Other / unclassified 2 g Intravenous
Comparator Ciprofloxacin Small molecule 750 mg Intravenous
Comparator Ciprofloxacin Small molecule 1000 mg Intravenous
Comparator Doxycycline Small molecule 200 mg Oral
Comparator Fusidic Acid Unknown 500 mg Oral
Comparator Levofloxacin Small molecule 500 mg Intravenous
Comparator Levofloxacin Small molecule 750 mg Intravenous
Comparator Linezolid Other / unclassified 600 mg Intravenous
Comparator Rifampin Small molecule 10 mg/kg Other
Comparator trimethoprim-sulfamethoxazole Unknown 800 mg Intravenous

Indications